Article Information
vol. 46 no. 1 250-254
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 22, 2015
- Accepted March 30, 2015
- Published online June 30, 2015.
Copyright & Usage
Copyright ©ERS 2015
Author Information
- Alvar Agustí1⇑,
- Stephen Rennard2,
- Lisa D. Edwards3,
- William MacNee4,
- Emiel Wouters5,
- Bruce Miller6,
- Ruth Tal-Singer6,
- Hana Mullerova7 and
- Bartolomé Celli8
- on behalf of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
- 1Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, Spain
- 2Dept of Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE, USA
- 3Clinical Statistics, GlaxoSmithKline R&D, Research Triangle Park, NC, USA
- 4ELEGI Labs, University of Edinburgh, Edinburgh, UK
- 5Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
- 6Respiratory Therapy Area Unit, GlaxoSmithKline R&D, King of Prussia, PA, USA
- 7Worldwide Epidemiology, GlaxoSmithKline R&D, Uxbridge, England
- 8Dept of Respiratory Medicine, Brigham and Women's Hospital, Boston, MA, USA
- Alvar Agustí, Institut del Tòrax. Hospital Clínic, Universitat de Barcelona, Villarroel 170, Escala 3, Planta 5, 08036 Barcelona, Spain. E-mail: alvar.agusti{at}clinic.ub.es.
Funding
GlaxoSmithKline